InMode to Present at the 25th Annual Needham Virtual Healthcare Conference
InMode (Nasdaq: INMD) announced that CEO Moshe Mizrahy and CFO Yair Malca will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026, at 11:00 AM Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InMode (Nasdaq: INMD) announced that CEO Moshe Mizrahy and CFO Yair Malca will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026, at 11:00 AM Eastern Time. The session is a fireside chat moderated by Michael Matson.
A live webcast of the presentation will be available and InMode will hold virtual one-on-one investor meetings the same day; scheduling is via Needham representatives and additional event details are on the company's investor relations site.
Details
News Market Reaction – INMD
On Mar 24, the day this news came out, INMD closed 0.22% below the previous close.
Data tracked by StockTitan Argus for the Mar 24 session.
Key Figures
- Conference date
- April 13, 2026
- Needham Virtual Healthcare Conference presentation
- Presentation time
- 11:00 am Eastern Time
- Scheduled fireside chat at Needham conference
- Current price
- $13.73
- Pre-news trading level vs. 52-week range
- 52-week range
- $12.72–$19.088
- Current price 7.94% above low, 28.07% below high
- Market cap
- $857,243,888
- Equity value before Needham conference announcement
Historical Context
-
Authorized buyback up to about 10% of shares outstanding.
-
Announced March presentations at Barclays and Oppenheimer healthcare conferences.
-
Committee ended potential-transaction process after deeming proposals inadequate.
-
Reported Q4 and FY 2025 results with 2026 revenue and EPS guidance.
-
Planned CFO-led investor meetings at BTIG MedTech conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM,
The fireside chat, moderated by Michael Matson, Senior Equity Analyst, is scheduled for 11:00 am Eastern Time on Monday, April 13, and a live webcast of the presentation can be accessed here. InMode will also hold virtual one-on-one investor meetings that same day. To schedule a meeting, please contact your Needham representative.
For more information about the event, visit InMode's investor relations site here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Logo - https://mma.prnewswire.com/media/1064477/5878507/InMode_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-to-present-at-the-25th-annual-needham-virtual-healthcare-conference-302722319.html
SOURCE InMode Ltd.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.